FDA Import Refusal 336-3125023-5/1/1 — Afriplex (Pty) Ltd.
The FDA refused shipment 336-3125023-5/1/1 from Afriplex (Pty) Ltd. (South Africa) on January 4, 2017. The refused product falls under Drugs and Biologics — MISCELLANEOUS PATENT MEDICINES, ETC.. Cited charges: 118,3280,75 This firm has 5 or more other import refusals on record.
Refusal Details
- Date
- January 4, 2017
- Country
- South Africa
- Product Category
- Drugs and Biologics
- Product Code
- 66VBL99 MISCELLANEOUS PATENT MEDICINES, ETC.
- Charges
- 118,3280,75